Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.02
(2.29%)
CNY 4.02
(2.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 715.24 Million CNY | -8.56% |
| 2022 | 782.23 Million CNY | -6.96% |
| 2021 | 840.78 Million CNY | -33.07% |
| 2020 | 1.25 Billion CNY | -12.59% |
| 2019 | 1.43 Billion CNY | -3.67% |
| 2018 | 1.49 Billion CNY | -15.09% |
| 2017 | 1.75 Billion CNY | 14.62% |
| 2016 | 1.53 Billion CNY | 23.91% |
| 2015 | 1.23 Billion CNY | 16.26% |
| 2014 | 1.06 Billion CNY | -1.58% |
| 2013 | 1.08 Billion CNY | 36.47% |
| 2012 | 792.27 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 619.91 Million CNY | -23.26% |
| 2024 Q1 | 807.84 Million CNY | 12.95% |
| 2024 Q3 | 715.74 Million CNY | 15.46% |
| 2023 Q2 | 783.71 Million CNY | -3.02% |
| 2023 Q1 | 808.1 Million CNY | 3.31% |
| 2023 FY | 715.24 Million CNY | -8.56% |
| 2023 Q4 | 715.24 Million CNY | -3.23% |
| 2023 Q3 | 739.1 Million CNY | -5.69% |
| 2022 Q3 | 708.09 Million CNY | 0.52% |
| 2022 Q1 | 836.06 Million CNY | -0.56% |
| 2022 Q2 | 704.42 Million CNY | -15.74% |
| 2022 FY | 782.23 Million CNY | -6.96% |
| 2022 Q4 | 782.23 Million CNY | 10.47% |
| 2021 Q4 | 840.78 Million CNY | 3.97% |
| 2021 FY | 840.78 Million CNY | -33.07% |
| 2021 Q2 | 842.99 Million CNY | -32.15% |
| 2021 Q3 | 808.64 Million CNY | -4.07% |
| 2021 Q1 | 1.24 Billion CNY | -1.1% |
| 2020 Q4 | 1.25 Billion CNY | 0.23% |
| 2020 Q2 | 1.25 Billion CNY | -6.17% |
| 2020 Q1 | 1.33 Billion CNY | -6.85% |
| 2020 FY | 1.25 Billion CNY | -12.59% |
| 2020 Q3 | 1.25 Billion CNY | -0.22% |
| 2019 Q3 | 1.34 Billion CNY | -5.63% |
| 2019 Q2 | 1.42 Billion CNY | -2.47% |
| 2019 Q4 | 1.43 Billion CNY | 7.08% |
| 2019 Q1 | 1.45 Billion CNY | -2.26% |
| 2019 FY | 1.43 Billion CNY | -3.67% |
| 2018 Q1 | 1.82 Billion CNY | 3.72% |
| 2018 FY | 1.49 Billion CNY | -15.09% |
| 2018 Q4 | 1.49 Billion CNY | -3.67% |
| 2018 Q3 | 1.54 Billion CNY | -12.3% |
| 2018 Q2 | 1.76 Billion CNY | -3.1% |
| 2017 Q3 | 1.56 Billion CNY | 4.34% |
| 2017 Q4 | 1.75 Billion CNY | 12.28% |
| 2017 FY | 1.75 Billion CNY | 14.62% |
| 2017 Q1 | 1.5 Billion CNY | -1.94% |
| 2017 Q2 | 1.49 Billion CNY | -0.21% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | 1.53 Billion CNY | 0.0% |
| 2016 FY | 1.53 Billion CNY | 23.91% |
| 2015 FY | 1.23 Billion CNY | 16.26% |
| 2014 FY | 1.06 Billion CNY | -1.58% |
| 2013 FY | 1.08 Billion CNY | 36.47% |
| 2012 FY | 792.27 Million CNY | 0.0% |